With an ever-increasing project demand from our clients in Japan, and as part of our Asia expansion plan, we are delighted to announce the opening of our new Tokyo office. Pharmaspectra has been working with Japan-based clients for 15 years, providing the most comprehensive coverage of local science available through our world-leading data lake. Having a dedicated team in the country will enable us to better serve our clients and local market needs in an even more targeted and effective way.
Pharmaspectra’s Japanese subsidiary will be led by Hisanobu (Nobu) HIRAYAMA. Nobu joins us from Truven/IBM Watson Health where he was VP and Head of Japan. He brings a wealth of pharmaceutical sales, consulting and CRM experience, and previously held roles at PWC and IMS Health.
Our new Japanese office builds on our existing global physical presence in Europe, North America, India and Australia, and leverages our ability to deliver transformative data, KOL analytics and measurement of scientific leadership in all diseases, in all parts of the world.